Skip to main content

CollPlant Biotechnologies Ltd

CLGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001631487

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding CollPlant Biotechnologies Ltd changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CLGN: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders1620+4
Shares1.72M1.74M+16.8K (+1.0%)
Value$19.5M$14.3M−$5.14M (−26.4%)

New holders (7)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CLGN in Q2 2022
InstitutionSharesValue% of portfolio
LPL Financial LLC45,070$361.0K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)23,210$189.0K0.00%
Simon Quick Advisors, LLC15,676$139.0K0.02%
Private Advisor Group, LLC12,862$103.0K0.00%
Cohanzick Management, LLC2,000$16.0K0.00%
Tower Research Capital LLC (TRC)892$7.00K0.00%
Venture Visionary Partners LLC115$9200.00%

Sold out (3)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CLGN in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Simplex Trading, LLC825$9.00K
Advisor Group Holdings, Inc.248$3.00K
Wells Fargo & Company100$1.00K